These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34830370)

  • 1. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions.
    Pirlog R; Drula R; Nutu A; Calin GA; Berindan-Neagoe I
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
    Chen B; Dragomir MP; Fabris L; Bayraktar R; Knutsen E; Liu X; Tang C; Li Y; Shimura T; Ivkovic TC; De Los Santos MC; Anfossi S; Shimizu M; Shah MY; Ling H; Shen P; Multani AS; Pardini B; Burks JK; Katayama H; Reineke LC; Huo L; Syed M; Song S; Ferracin M; Oki E; Fromm B; Ivan C; Bhuvaneshwar K; Gusev Y; Mimori K; Menter D; Sen S; Matsuyama T; Uetake H; Vasilescu C; Kopetz S; Parker-Thornburg J; Taguchi A; Hanash SM; Girnita L; Slaby O; Goel A; Varani G; Gagea M; Li C; Ajani JA; Calin GA
    Gastroenterology; 2020 Dec; 159(6):2146-2162.e33. PubMed ID: 32805281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CCAT2 acts as an oncogene in osteosarcoma through regulation of miR-200b/VEGF.
    Liu J; Kong D; Sun D; Li J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2994-3003. PubMed ID: 31322006
    [No Abstract]   [Full Text] [Related]  

  • 5. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
    Ling H; Spizzo R; Atlasi Y; Nicoloso M; Shimizu M; Redis RS; Nishida N; Gafà R; Song J; Guo Z; Ivan C; Barbarotto E; De Vries I; Zhang X; Ferracin M; Churchman M; van Galen JF; Beverloo BH; Shariati M; Haderk F; Estecio MR; Garcia-Manero G; Patijn GA; Gotley DC; Bhardwaj V; Shureiqi I; Sen S; Multani AS; Welsh J; Yamamoto K; Taniguchi I; Song MA; Gallinger S; Casey G; Thibodeau SN; Le Marchand L; Tiirikainen M; Mani SA; Zhang W; Davuluri RV; Mimori K; Mori M; Sieuwerts AM; Martens JW; Tomlinson I; Negrini M; Berindan-Neagoe I; Foekens JA; Hamilton SR; Lanza G; Kopetz S; Fodde R; Calin GA
    Genome Res; 2013 Sep; 23(9):1446-61. PubMed ID: 23796952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.
    Yu Y; Nangia-Makker P; Farhana L; Majumdar APN
    Mol Cancer; 2017 Sep; 16(1):155. PubMed ID: 28964256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.
    Ma Y; Hu X; Shang C; Zhong M; Guo Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression.
    Niu C; Wang L; Ye W; Guo S; Bao X; Wang Y; Xia Z; Chen R; Liu C; Lin X; Huang X
    J Cell Physiol; 2020 Sep; 235(9):6307-6320. PubMed ID: 32037568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53.
    Zhang Z; Wang X; Wang Y; Zhou D; Wu H; Cheng W; Wang Q; Zheng G; Wang J; Gu J
    J Biochem Mol Toxicol; 2022 Nov; 36(11):e23176. PubMed ID: 35968984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer.
    Hua F; Li CH; Chen XG; Liu XP
    Oncol Res; 2018 Mar; 26(2):241-247. PubMed ID: 28550684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.
    Sun SL; Shu YG; Tao MY
    Mol Cell Biochem; 2020 May; 468(1-2):69-82. PubMed ID: 32236863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
    Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
    J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
    Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
    Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R; Zhao XL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.